Logo
Home|Clinics & Hospitals|Departments or Services|Insurance Companies|Health News|Contact Us
HomeClinics & HospitalsDepartments or ServicesInsurance CompaniesHealth NewsContact Us

Search

SMi's 5th Annual KOL Management Conference, 26-27 September 2012, London

Date: Jun-12-2012
SMi is proud to present their 5th annual KOL Management on 26th & 27th September 2012, in London, the conference focused to keep our audience up-to-date with developments in the ever-changing KOL sphere.

Every pharmaceutical company knows how important it is to develop a successful KOL management program. Audrey Craven, President, European Federation of Neurological Associations (EFNA) talks about understanding the key needs and making it work. Hear directly from Audrey Craven and other Key Opinion Leaders on defining the landscape and developing a successful KOL management program for your organisation.

Bringing together key opinion leaders and pharmaceutical representatives, this event is a unique opportunity to gain an insight into current relations and how to develop and maintain a professional working relationship.

Reasons why you should attend:
Hear directly from Key Opinion Leaders
Find out about the Global Health agenda
Identify and engage with KOLs through effective social media and traditional channels
Gain an insight into current transparent and flexible relationships
Improve your relationship with key leaders
Find out how the Bribery Act affects you
Establishing the return on investment for your KOL and MSL management
Develop a successful KOL management program

Keynote Speakers include:
Audrey Craven, President, European Federation of Neurological Associations (EFNA)
Alexander Natz, Secretary General, European Confederation of Pharmaceutical Entrepreneurs (EUCOPE)
Mario Ottiglio, Associate Director, Public Affairs & Global Health Policy, IFPMA
Michal Konstacky, Medical Affairs Director, Takeda
Keith Allan, Head of Global Advocacy, Novartis
Sanjita Panchal, Medical Scientific Liaison, Merck
Neil Ranasinghe, Medical Sciences Manager, Oncology, Immunology & Neuroscience, Bristol-Myers Squibb

Visit our website here: http://www.smi-online.co.uk/goto/2012kol-uk31.asp

Alternatively contact Shilan Chandi on tel: +44 (0) 20 7827 6738 or email: schandi@smi-online.co.uk

Courtesy: Medical News Today
Note: Any medical information available in this news section is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional.